Anesthesia And Respiratory Devices Market Analysis & Forecast 2025-2032

Anesthesia And Respiratory Devices Market Size and Forecast – 2025 to 2032

The Global Anesthesia and Respiratory Devices Market is estimated to be valued at USD 56.12 Bn in 2025 and is expected to reach USD 84.50 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6% from 2025 to 2032.

Key Takeaways of the Anesthesia and Respiratory Devices Market:

• By product type, the anesthesia devices segment is expected to contribute the highest share of the market with 42.1% in 2025.
• By end user, the hospitals and clinics segment is expected to contribute the highest share of the market with 33.2% in 2025.
• By gender, the male segment is expected to contribute the highest share of the market with 52.3% in 2025.
• North America is expected to top the global market with 42.3% share in 2025, followed by Asia Pacific with 25.5% share in 2025.

Market Overview:

The anesthesia and respiratory devices industry is witnessing positive growth trends over the past few years. There is increasing adoption of anesthesia machines owing to the rising number of surgical procedures globally. Technological advancements in respiratory care devices with integrated software solutions are further supporting the market growth. Growing prevalence of respiratory diseases due to rising air pollution levels and increasing global geriatric population are key factors driving the demand for respiratory devices. Furthermore, favorable government initiatives for promoting effective respiratory care are expected to boost the anesthesia and respiratory devices market during the forecast period. However, high cost of innovative respiratory devices may hinder the market growth to some extent.

Segmental Insights

To learn more about this report, Request sample copy

Product Type Insights - Cost-effectiveness contributes to the highest market share of anesthesia devices

In terms of product type, the anesthesia devices segment is expected to contribute the highest share of the market with 42.1% in 2025 owing to their widespread usage and cost-effectiveness. As anesthesia machines, workstations and monitors are reusable, they prove more economical for hospitals and clinics in the long run compared to disposables. Their versatility also allows anesthesia providers to manage a variety of surgical procedures while ensuring patient safety. Regular advancements have further increased the functionality of these devices, through added features such as touchscreens and connectivity options. This has augmented their acceptance rate among healthcare organizations. Moreover, the demand continues to rise domestically as well as internationally with growing access to surgical treatments. High disease prevalence also fuels the need for anesthesia devices to support complex surgeries worldwide.

End User Insights - Hospitals and clinics have the infrastructure and expertise to effectively utilize high-end equipment

In terms of end user, the hospitals and clinics segment is expected to contribute the highest share of the market with 33.2% in 2025 given their large-scale infrastructure and expertise. They cater to a high patient inflow requiring surgery or respiratory support daily. Moreover, hospitals are well-equipped to procure sophisticated anesthesia and respiratory devices. Experienced anesthetists and technicians enable maximizing the benefits of advanced equipment. Comprehensive insurance coverage for in-patient procedures also makes hospitals a favorable option. This ensures continuous demand from top-tier end users who can leverage cutting-edge technology.

Gender Insights - Higher risks of respiratory ailments in males lead to greater usage of devices

In terms of gender, the male segment is expected to contribute the highest share of the market with 52.3% in 2025 owing to increased susceptibility to respiratory disorders. Physiological traits like narrower airways make men prone to conditions such as Chronic obstructive pulmonary disease COPD and asthma. Occupational hazards from industries also impact the respiratory health of many male workers. Moreover, lifestyle factors like smoking and alcohol consumption remain prevalent among men. This elevates the risks manifold. Consequently, diagnostic tests and treatments requiring devices are more frequent for respiratory issues affecting the male population. Even during procedures, men may need personalized settings on anesthesia and ventilation products in light of varied anatomy. All these contribute to their larger consumption of relevant equipment.

Regional Insights

To learn more about this report, Request sample copy

North America Anesthesia And Respiratory Devices Market Trends

In North America, the dominance in the anesthesia and respiratory devices market with a share of 42.3% in 2025 can be attributed to factors such as the strong presence of major players, favorable government policies supporting medical technology innovation and adoption, and higher healthcare expenditure. Countries like the U.S. and Canada have seen significant investments from players aiming to develop advanced products.

Asia Pacific Anesthesia And Respiratory Devices Market Trends

Meanwhile, the Asia Pacific region exhibits the fastest growth with a share of 25.5% in 2025, led by countries like China, India, Japan, and South Korea. Rapid economic development and rising affluence have increased access to healthcare in the region. Governments are focusing on strengthening their healthcare systems to meet domestic demand as well as tap into medical tourism. Leading global companies like GE Healthcare are shifting their low-cost manufacturing base to the region and collaborating with local players.

Anesthesia and Respiratory Devices Market Outlook for Key Countries

United States Anesthesia and Respiratory Devices Market Trends

In 2024, the U.S. held the largest share of the global anesthesia and respiratory devices market, driven by favorable reimbursement policies encouraging device adoption. For instance,, a key milestone occurred in March 2024 with the introduction of the Supplemental Oxygen Access Reform (SOAR) Act by a U.S. Congressman, aimed at enhancing access to supplemental oxygen for Medicare beneficiaries. This legislation is expected to significantly boost the nationwide adoption of oxygen concentrators. Additionally, increasing healthcare spending in the U.S. is fueling the anesthesia and respiratory devices market growth.

U.K. Anesthesia and Respiratory Devices Market Trends

The U.K. held a significant share of the anesthesia and respiratory devices market in 2024, driven by active participation from market players and organizations in creating cost-effective respiratory solutions. Notably, for instance, in February 2022, OxVent, a low-cost, rapidly deployable ventilator developed through a collaboration between the University of Oxford and King’s College London, received approval for large-scale production and adoption as a social enterprise.

France Anesthesia and Respiratory Devices Market Trends

The anesthesia and respiratory devices market in France has been positively impacted by the proactive efforts of market players. For instance, in August 2020, ZOOOK, a France-based lifestyle brand, launched the Oximate Finger Tip Pulse Oximeter. Designed for precision, this compact device monitors pulse rates and blood oxygen saturation levels, featuring a single-button function for ease of use and a comfortable design to enhance user experience. By expanding its health-tech product lineup with this device, ZOOOK has strengthened its market position and supported the growth of the pulse oximeter market in France.

India Anesthesia And Respiratory Devices Market Trends

The anesthesia and respiratory devices market in India is bolstered by increasing initiatives. For instance,, in May 2021, Koninklijke Philips N. V., a health technology company, announced a 7% price reduction on its oxygen concentrators in India, reflecting the government's custom duty reduction. This move lowered the maximum retail price (MRP) of the device from USD 1,012 to USD 940, making it more accessible to consumers.

Market Players, Key Devlopment, and Competitive Intelligence

Get actionable strategies to beat competition: Request sample copy

Key Developments:

• In November 2024, Mindray, a medical device company, introduced significant upgrades to its A7 and A5 anesthesia systems as part of the A Series Anesthesia lineup. These enhancements feature advanced technologies designed to improve anesthesia precision, boost patient safety, and enhance perioperative efficiency.
• In May 2024, Masimo, a leader in innovative medical technologies, partnered with Medable Inc., a leading healthcare technology company, to incorporate its MightySat Rx pulse oximeter into Medable’s evidence-generation platform. This integration supports eight large-scale pharmaceutical trials focused on breast and lung cancer, involving over 3,000 patients across 25 countries.
• In April 2024, Royal Philips, a global leader in health technology, announced plans for a new R&D center within its Healthcare Innovation Center (HIC) in Maharashtra, India. Set to be operational within two years, the facility will focus on sleep & respiratory care, precision diagnosis, image guided therapy, and monitoring.
• In June 2022, Medtronic and GE Healthcare, both renowned for healthcare innovation, received U.S. FDA 510(k) clearance and CE Mark approval to integrate Microstream capnography and INVOS regional oximetry into GE’s CARESCAPE precision monitoring platform. This advancement enhances the ability to monitor respiratory compromise and predict perioperative complications.

Top Strategies Followed by Global Anesthesia and Respiratory Devices Market Players

• Established players focus heavily on R&D investments to innovate high-performance products
  • For instance, in October 2024, Finland-based respiratory health innovator, WellO2, introduced its latest breathing exercise device at the Pharmacy Show 2024. Designed for individuals seeking drug-free solutions to improve respiratory function, the device offers proven benefits for managing chronic conditions such as asthma, sleep apnea, COPD, and other breathing disorders.
• Mid-level companies are addressing unique market needs by focusing on specific medical conditions, developing specialized devices that cater to particular patient populations
  • For instance, in June 2024, Savara Inc., a clinical-stage biopharmaceutical company, focused on rare respiratory diseases, presented the top-line results from the pivotal Phase 3 IMPALA-2 clinical trial. This trial assessed the efficacy and safety of molgramostim , an inhaled form of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF).
• Small players like Ventec Life Systems target niche markets with unique products tailored for specific respiratory conditions, such as portable ventilators for home use. Small-scale companies are adopting cutting-edge technologies. For instance, companies like OxyGo are utilizing advanced oxygen delivery systems to remain competitive in the market.

Emerging Startups - Anesthesia and Respiratory Devices Industry Ecosystem

• In the area of innovative technologies, startups are developing smart ventilators integrated with sensors and AI algorithms to optimize breath delivery. Some examples include Anthropic, which created an AI-powered closed-loop ventilator able to learn patient needs. These advanced ventilators could personalize treatments and reduce physician workload.
• Regarding sustainable solutions, companies like AirXT and Innovo Technology develop recycled or eco-friendly respiratory products. AirXT makes ventilator filters from bioplastics while Innovo produces anesthesia machines with reduced e-waste. Their contributions may help lower costs and cut the industry's carbon footprint over time.
• Startups also address unique niche markets. BioIntelliSense focuses on compact remote monitoring devices for ambulatory and pediatric patients. Other examples are Anthropic and Innovotech, which created transport ventilators tailored for ground and aeromedical evacuation. Through specialized solutions, these emerging companies expand the reach of respiratory and anesthesia care globally.

Market Report Scope

Market Dynamics

Discover market dynamics shaping the industry: Request sample copy

Market Driver - Increasing incidence of respiratory disorders

The global burden of respiratory diseases has been steadily rising over the past few decades. Changing lifestyle patterns, rising air pollution levels, growing prevalence of smoking and tobacco consumption, increased allergen exposure have boosted cases of chronic respiratory conidiations. Respiratory illnesses like asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and lung cancer have showcased an upward trend worldwide according to the latest WHO data. Respiratory diseases directly impact the functioning of the lungs and respiratory tract. Many conditions require long-term treatment and management of symptoms. The deterioration of lung health also reduces the quality of life for patients. For instance, according to the WHO’s May 2024 update, asthma is a major non-communicable disease and one of the most common chronic conditions among children. The under-diagnosis and under-treatment of asthma, especially in low- and middle-income countries, highlight the need for devices like pulse oximeters for effective diagnosis and monitoring, driving growth in the anesthesia and respiratory devices market.

Market Challenge - High costs associated with advanced devices

The global anesthesia and respiratory devices market faces the major challenge of high costs associated with advanced devices. The R&D and manufacturing of sophisticated devices that can perform complex functions and monitor critical patient parameters requires substantial investments. This makes these devices highly expensive for hospitals and healthcare facilities in many developing regions. The costs are eventually passed on to patients as out-of-pocket expenses, making such life-saving devices inaccessible to a large population base that has low or limited health insurance coverage. device manufacturers find it difficult to price their products affordably without comprising on quality while also aiming for reasonable profit margins. The high capital expenditure requirements also restrict new players from entering this market, concentrating supply among a few major multinational corporations. While demand exists, the inability of a section of patients and hospitals to bear high costs remains a significant roadblock for market growth.

Market Opportunity - Technological advancements in device manufacturing

The global anesthesia and respiratory devices market has strong opportunities arising from continuous technological advancements in device manufacturing. Major players are investing heavily in R&D to develop next-generation innovations with enhanced functionalities, material properties, miniaturization, connectivity, and data analytics capabilities. Advancements such as 3D printing, robotics, and artificial intelligence are enabling automated, digitalized, and personalized care. Device miniaturization allows for greater portability suited to home healthcare settings. Connectivity and integration of devices with health IT systems facilitate remote monitoring while generating valuable real-world data. Outsourcing production to contract manufacturers in lower-cost regions also helps reduce device prices. Such technologically-sadvanced products gain more acceptance among customers and expand the potential market reach.

Analyst Opinion (Expert Opinion)

• The global anesthesia and respiratory devices market is expected to witness steady growth over the forecast period owing to the increasing number of surgical procedures performed worldwide. Rise in chronic respiratory diseases such as asthma and COPD along with growing geriatric population will further propel the demand for anesthesia and respiratory devices. However, high costs associated with pulmonary drugs and devices may hamper the market growth. North America dominated the anesthesia and respiratory devices market in 2025 due to supportive healthcare infrastructure and rising healthcare spending in the region. Asia Pacific is projected to be the fastest growing regional market during the analysis period led by rapidly developing healthcare systems in China and India.
• On the devices front, anesthesia monitors are likely to remain most widely used products driven by increasing adoption of combined anesthesia systems. Respiratory care devices segment, on the other hand, will gain traction from rising cases of respiratory disorders. Key players operating in the market should capitalize on opportunities in emerging economies by partnering with regional hospitals to increase access to advanced respiratory care therapies. Companies should also focus on new product approvals and launches to get an edge over competitors. Development of user-friendly and cost-effective devices holds potential to significantly boost the market growth going forward.

Market Segmentation

• By Product Type Insights (Revenue, USD Bn, 2020 - 2032)
• • Anesthesia devices
    • Anesthesia Monitoring System
      • Advanced Anesthesia Monitoring
        • Anesthesia Gas Monitor
        • Depth of Anesthesia Monitors
        • Standalone Capnography Monitors
        • MRI Compatible Anesthesia Monitor
      • Basic Anesthesia Monitor
    • Anesthesia machines
      • Portable Anesthesia machines
      • Standalone Anesthesia machines
    • Anesthesia Workstation
    • Anesthesia Ventilators
    • Anesthesia Disposables
    • Accessories
  • Respiratory Devices
    • Therapeutic Devices
      • Positive Airway Pressure (PAP) Devices
      • Inhalers
      • Humidifiers
      • Oxygen Concentrators
      • Reusable Resuscitators
      • Respiratory Mask
      • Nitric Oxide Delivery Units
      • Others
    • Monitoring Devices
      • Pulse Oximeters
      • Capnographs
      • Gas Analyzers
    • Diagnostic Devices
      • Spirometer
      • Peak Flow Meters
      • Polysomnography Devices
      • Others
    • Consumables and Accessories
      • Tracheostomy Tubes
      • Others (Nasal Cannulas, etc.)
• By End User Insights (Revenue, USD Bn, 2020 - 2032)
• • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Homecare Settings
  • Diagnostic Laboratories
  • Others (Research Institutes)
• By Gender Insights (Revenue, USD Bn, 2020 - 2032)
• • Male
  • Female
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
• • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
• • GE Healthcare
  • Philips Healthcare
  • Drägerwerk AG
  • Masimo Corporation
  • Mindray Medical International Limited
  • Nihon Kohden Corporation
  • Teleflex Incorporated
  • Smiths Medical
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Getinge AB
  • Hill-Rom Holdings, Inc.
  • Covidien (Medtronic)
  • ResMed Inc.
  • Intersurgical Ltd.